nach oben

Erschienen in:

12.01.2021 | COVID-19 | COVID-19 Zur Zeit gratis

The impact of the COVID-19 pandemic on people with neurological disorders: an urgent need to enhance the health care system’s preparedness

verfasst von: Silvia Zullo, Francesca Ingravallo, Vittorio Crespi, Marta Cascioli, Roberto D’Alessandro, Marcella Gasperini, Chiara Lalli, Alessandra Lugaresi, Maura Marogna, Maurizio Mori, Ilaria Pesci, Francesca Pistoia, Corinna Porteri, Marcella Vedovello, Simone Veronese, Eugenio Pucci, Alessandra Solari, Gruppo di Studio “Bioetica e Cure Palliative” of the Italian Neurological Society

Erschienen in: Neurological Sciences | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Excerpt

Italy was the first nation in Europe to be affected by COVID-19 pandemic, and it was subjected to a level 1 national lockdown for almost 2 months (from March 9 to May 4, 2020) [1]. During the mandatory lockdown, 29,684 deaths due to COVID-19 were registered, 23,163 of which (78%) were in four Northern regions: Lombardy, Emilia Romagna, Piedmont, and Veneto [2]. This health emergency highlighted the imbalance existing between the needs of individuals (prevention, diagnosis, treatment) and available resources (services, supplies, professionals, and research). In particular, the reorganization of health services and the social distancing measures implemented to contain the spread of the SARS-CoV-2, together with people’s fears of being infected and the lack of targeted information campaigns, have led to a series of consequences for both patients and their families. As far as the neurological field is concerned, the impact of this “healthcare void” has been particularly remarkable for people suffering from chronic neurological conditions, as well as for those with neurological emergencies, and has resulted in worse health outcomes. In some instances, the criteria adopted for the allocation of health resources during the COVID-19 pandemic have penalized patients with neurological diseases [3]. …

Government of Italy. Decree of the President of the Council of Ministers 11 March 2020. https://www.gazzettaufficiale.it/eli/id/2020/03/11/20A01605/sg. Accessed 15 September 2020

Italian Ministry of Health. http://www.salute.gov.it/imgs/C_17_notizie_4694_0_file.pdf. Accessed 15 September 2020

Bersano A, Pantoni L (2020) On being a neurologist in Italy at the time of the COVID-19 outbreak. Neurology 94(21):905–906. https://doi.org/10.1212/WNL.0000000000009508CrossRefPubMed

Rubin MA, Bonnie RJ, Epstein L, Hemphill C, Kirschen M, Lewis A, Suarez JI, Ethics, Law, and Humanities Committee, a joint committee of the American Academy of Neurology, American Neurological Association, and Child Neurology Society; in collaboration with the Neurocritical Care Society Ethics Committee (2020) AAN position statement: the COVID-19 pandemic and the ethical duties of the neurologist. Neurology 95(4):167–172. https://doi.org/10.1212/WNL.0000000000009744

Fuentes B, Alonso de Leciñana M, Calleja-Castaño P, Carneado-Ruiz J, Egido-Herrero J, Gil-Núñez A, Masjuán-Vallejo J, Vivancos-Mora J, Rodríguez-Pardo J, Riera-López N, Ximénez-Carrillo Á, Cruz-Culebras A, Gómez-Escalonilla C, Díez-Tejedor E, en representación de los hospitales del Plan Ictus Madrid (2020) Impact of the COVID-19 pandemic on the organisation of stroke care. Madrid Stroke Care Plan. Neurologia 35(6):363–371PubMed

Leocani L, Diserens K, Moccia M, Caltagirone C (2020) Disability through COVID-19 pandemic: neurorehabilitation cannot wait. Eur J Neurol 27:e50–e51. https://doi.org/10.1111/ene.14320CrossRefPubMed

Brown EG, Chahine LM, Goldman SM, Korell M, Mann E, Kinel DR, Arnedo V, Marek KL, Tanner CM (2020) The effect of the COVID-19 pandemic on people with Parkinson’s disease. J Parkinsons Dis 10:1365–1377. https://doi.org/10.3233/JPD-202249CrossRefPubMedPubMedCentral

Cheong JLY, Goh ZHK, Marras C, Tanner CM, Kasten M, Noyce AJ, Movement Disorders Society Epidemiology Study Group (2020) The impact of COVID-19 on access to Parkinson’s disease medication. Mov Disord. https://doi.org/10.1002/mds.28293

Wirrell EC, Grinspan ZM, Knupp KG, Jiang Y, Hammeed B, Mytinger JR, Patel AD, Nabbout R, Specchio N, Cross JH, Shellhaas RA (2020) Care delivery for children with epilepsy during the COVID-19 pandemic: an international survey of clinicians. J Child Neurol:883073820940189. https://doi.org/10.1177/0883073820940189

10.

Provinciali L, Carlini G, Tarquini D, Defanti CA, Veronese S, Pucci E (2016) Need for palliative care for neurological diseases. Neurol Sci 37(10):1581–1587. https://doi.org/10.1007/s10072-016-2614-xCrossRefPubMed

11.

Bhaskar S, Bradley S, Israeli-Korn S, Menon B, Chattu VK, Thomas P, Chawla J, Kumar R, Prandi P, Ray D, Golla S, Surya N, Yang H, Martinez S, Ozgen MH, Codrington J, González EMJ, Toosi M, Hariya Mohan N, Menon KV, Chahidi A, Mederer Hengstl S (2020) Chronic neurology in COVID-19 era: clinical considerations and recommendations from the REPROGRAM Consortium. Front Neurol 11:664. https://doi.org/10.3389/fneur.2020.00664CrossRefPubMedPubMedCentral

12.

Hernández Ramos FJ, Palomino García A, Jiménez Hernández MD (2020) Neurology during the pandemic. Is COVID-19 changing the organisation of Neurology Departments? Neurologia 35(4):269–271. https://doi.org/10.1016/j.nrl.2020.04.009CrossRefPubMed

13.

Naccarato M, Scali I, Olivo S, Ajčević M, Buoite Stella A, Furlanis G, Lugnan C, Caruso P, Peratoner A, Cominotto F, Manganotti P (2020) Has COVID-19 played an unexpected “stroke” on the chain of survival? J Neurol Sci 414(15):1–4

14.

Ikenberg B, Hemmer B, Dommasch M, Kanz KG, Wunderlich S, Knier B (2020) Code stroke patient referral by emergency medical services during the public COVID-19 pandemic lockdown. J Stroke Cerebrovasc Dis 29(11):105175. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105175CrossRefPubMedPubMedCentral

15.

Esenwa C, Parides MK, Labovitz DL (2020) The effect of COVID-19 on stroke hospitalizations in New York City. J Stroke Cerebrovasc Dis 29(10):105114. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105114CrossRefPubMedPubMedCentral

16.

Markus HS, Brainin M (2020) COVID-19 and stroke-a global world stroke organization perspective. Int J Stroke 15(4):361–364. https://doi.org/10.1177/1747493020923472CrossRefPubMed

17.

Fridman S, Bullrich MB, Jimenez-Ruiz A, Costantini P, Shah P, Just C, Vela-Duarte D, Linfante I, Sharifi-Razavi A, Karimi N, Bagur R, Debicki DB, Gofton TE, Steven DA, Sposato LA (2020) Stroke risk, phenotypes, and death in COVID-19: systematic review and newly reported cases. Neurology 15. https://doi.org/10.1212/WNL.0000000000010851

18.

Montaner J, Barragán-Prieto A, Pérez-Sánchez S, Escudero-Martínez I, Moniche F, Sánchez-Miura JA, Ruiz-Bayo L, González A (2020) Break in the stroke chain of survival due to COVID-19. Stroke 51(8):2307–2314. https://doi.org/10.1161/STROKEAHA.120.030106CrossRefPubMed

19.

Baracchini C, Pieroni A, Viaro F, Cianci V, Cattelan AM, Tiberio I, Munari M, Causin F (2020) Acute stroke management pathway during Coronavirus-19 pandemic. Neurol Sci 41(5):1003–1005. https://doi.org/10.1007/s10072-020-04375-9CrossRefPubMed

20.

Bersano A, Kraemer M, Touzé E, Weber R, Alamowitch S, Sibon I, Pantoni L (2020) Stroke care during the COVID-19 pandemic: experience from three large European countries. Eur J Neurol 27:1794–1800. https://doi.org/10.1111/ene.14375CrossRefPubMed

21.

Sonekar HB, Ponnaiah M (2020) Emergence of coronavirus (COVID-19) outbreak: anthropological and social science perspective. Disaster Med Public Health Prep:1–3. https://doi.org/10.1017/dmp.2020.203

22.

Brivio E, Oliveri S, Pravettoni G (2020) Empowering communication in emergency contexts: reflections from the Italian coronavirus outbreak. Mayo Clin Proc 9(5):849–851. https://doi.org/10.1016/j.mayocp.2020.03.021CrossRef

23.

Finset A, Bosworth H, Butow P, Gulbrandsen P, Hulsman RL, Pieterse AH, Street R, Tschoetschel R, van Weert J (2020) Effective health communication - a key factor in fighting the COVID-19 pandemic. Patient Educ Couns 103(5):873–876. https://doi.org/10.1016/j.pec.2020.03.027CrossRefPubMedPubMedCentral

24.

Zedde M, Pezzella FR, Paciaroni M, Corea F, Reale N, Toni D, Caso V (2020) Stroke care in Italy: an overview of strategies to manage acute stroke in COVID-19 time. Eur Stroke J 5(3):222–229. https://doi.org/10.1177/2396987320942622CrossRefPubMedPubMedCentral

25.

Paolucci M, Biguzzi S, Cordici F, Lotti EM, Morresi S, Romoli M, Strumia S, Terlizzi R, Vidale S, Menarini M, Ruggiero M, Valentino A, Longoni M (2020) Impact of COVID-19 pandemic on acute stroke care: facing an epidemiological paradox with a paradigm shift. Neurol Sci. https://doi.org/10.1007/s10072-020-04914-4

26.

Candeloro E, Carimati F, Tabaee Damavandi P, Princiotta Cariddi L, Banfi P, Clemenzi A, Gallazzi M, Mauri M, Rebecchi V, Baruzzi F, Giorgianni A, Tozzi M, Bianchi M, Ageno W, Versino M (2020) An example of a stroke unit reshaping in the context of a regional hub and spoke system in the COVID-19 era. Front Neurol 11:1029. https://doi.org/10.3389/fneur.2020.01029CrossRefPubMedPubMedCentral

27.

Postiglione E, Pizza F, Ingravallo F, Vignatelli L, Filardi M, Mangiaruga A, Antelmi E, Moresco M, Oriolo C, Pagotto U, Plazzi G (2020) Impact of COVID-19 pandemic lockdown on narcolepsy type 1 management. Brain Behav. https://doi.org/10.1002/brb3.1955

28.

De Marchi F, Sarnelli MF, Serioli M, De Marchi I, Zani E, Bottone N, Ambrosini S, Garone R, Cantello R, Mazzini L, CANPALS Study Group (2020) Telehealth approach for amyotrophic lateral sclerosis patients: the experience during COVID-19 pandemic. Acta Neurol Scand. https://doi.org/10.1111/ane.1337

29.

Motolese F, Magliozzi A, Puttini F, Rossi M, Capone F, Karlinski K, Stark-Inbar A, Yekutieli Z, di Lazzaro V, Marano M (2020) Parkinson’s disease remote patient monitoring during the COVID-19 lockdown. Front Neurol 11:567413. https://doi.org/10.3389/fneur.2020.567413CrossRefPubMedPubMedCentral

30.

Delussi M, Gentile E, Coppola G, Prudenzano AMP, Rainero I, Sances G, Abagnale C, Caponnetto V, de Cesaris F, Frattale I, Guaschino E, Marcinnò A, Ornello R, Pistoia F, Putortì A, Roca ME, Roveta F, Lupi C, Trojano M, Pierelli F, Geppetti P, Sacco S, de Tommaso M (2020) Investigating the effects of COVID-19 quarantine in migraine: an observational cross-sectional study from the Italian National Headache Registry (RICe). Front Neurol 11:597881. https://doi.org/10.3389/fneur.2020.597881CrossRefPubMedPubMedCentral

31.

Sormani MP (2020) An Italian programme for COVID-19 infection in multiple sclerosis. Lancet Neurol 2020

32.

Muppidi S, Guptill JT, Jacob S, Li Y, Farrugia ME, Guidon AC, Tavee JO, Kaminski H, Howard JF Jr, Cutter G, Wiendl H, Maas MB, Illa I, Mantegazza R, Murai H, Utsugisawa K, Nowak RJ, Guidon AC, Tyagi A, Sousa AP, Amato AA, Pinto A, Roy B, Carmichael C, Dodig D, Burke G, Cutter GR, Kaminski HJ, Wiendl H, Murai H, Lee I, Illa I, Guptill J, Howard JF Jr, Caress J, Pritchard J, Tavee JO, Vissing J, Best K, Utsugisawa K, Ramezani M, Maas M, Farrugia ME, Hehir MK, Kaku M, Esquivel NJ, Gallagher P, Maddison P, Ambrose PA, Mantegazza RE, Nowak RJ, Do Campo RV, Jacob S, Saba S, Nafissi S, Itoyama S, Muppidi S, Viegas SV, Marshall V, Li YL (2020) COVID-19-associated risks and effects in myasthenia gravis (CARE-MG). Lancet Neurol 19(12):970–971. https://doi.org/10.1016/S1474-4422(20)30413-0CrossRefPubMedPubMedCentral

33.

Christian MD, Joynt GM, Hick JL, Colvin J, Danis M, Sprung CL, European Society of Intensive Care Medicine's Task Force for intensive care unit triage during an influenza epidemic or mass disaster (2020) Critical care triage. Recommendations and standard operating procedures for intensive care unit and hospital preparations for an influenza epidemic or mass disaster. Intensive Care Med 36(Suppl 1):S55–S64. https://doi.org/10.1007/s00134-010-17650

34.

Strosberg MA (2006) Allocating scarce resources in a pandemic: ethical and public policy dimensions. Ethics Journal of the American Medical Association 8(4):241–244

35.

Veatch RM (2005) Disaster preparedness and triage: justice and the common good. Mt Sinai J Med 72:236–241 Available at: http://www.mssm.edu/msjournal/72/72_4_pages_236_241.pdfPubMed

36.

van der Meulen M, Kleineberg NN, Schreier DR, García-Azorin D, di Lorenzo F (2020) COVID-19 and neurological training in Europe: from early challenges to future perspectives. Neurol Sci 41:3377–3379CrossRef

37.

Chaet D, Clearfield R, Sabin JE, Skimming K (2017) Council on Ethical and Judicial Affairs American Medical Association. Ethical practice in telehealth and telemedicine. J Gen Intern Med 32(10):1136–1140CrossRef

38.

Hopkins SA, Lovick R, Polak L, Bowers B, Morgan T, Kelly MP, Barclay S (2020) Reassessing advance care planning in the light of covid-19. BMJ 369:m1927. https://doi.org/10.1136/bmj.m1927CrossRefPubMed

39.

De Panfilis L, Giorgi Rossi P, Mazzini E, Pistolesi L, Ghirotto L, Noto A, Cuocolo S, Costantini M (2020) Knowledge, opinion and attitude about the Italian law on advance directives: a population-based survey. J Pain Symptom Manag S0885–3924(20):30561–30563. https://doi.org/10.1016/j.jpainsymman.2020.06.020CrossRef

40.

Oseran AS, Nash D, Kim C, Moisuk S, Lai PY, Pyhtila J, Sequist TD, Wasfy JH (2020) Changes in hospital admissions for urgent conditions during COVID-19 pandemic. Am J Manag Care 26(8):327–328. https://doi.org/10.37765/ajmc.2020.43837

41.

Zhao J, Li H, Kung D, Fisher M, Shen Y, Liu R (2020) Impact of the COVID-19 epidemic on stroke care and potential solutions. Stroke 51(7):1996–2001CrossRef

42.

Jasne AS, Chojecka P, Maran I, Mageid R, Eldokmak M, Zhang Q, Nystrom K, Vlieks K, Askenase M, Petersen N, Falcone GJ, Wira CR III, Lleva P, Zeevi N, Narula R, Amin H, Navaratnam D, Loomis C, Hwang DY, Schindler J, Hebert R, Matouk C, Krumholz HM, Spudich S, Sheth KN, Sansing LH, Sharma R (2020) Stroke code presentations, interventions, and outcomes before and during the COVID-19 pandemic. Stroke 51(9):2664–2673. https://doi.org/10.1161/STR.0000000000000347CrossRefPubMedPubMedCentral

Titel: The impact of the COVID-19 pandemic on people with neurological disorders: an urgent need to enhance the health care system’s preparedness
verfasst von: Silvia Zullo
Francesca Ingravallo
Vittorio Crespi
Marta Cascioli
Roberto D’Alessandro
Marcella Gasperini
Chiara Lalli
Alessandra Lugaresi
Maura Marogna
Maurizio Mori
Ilaria Pesci
Francesca Pistoia
Corinna Porteri
Marcella Vedovello
Simone Veronese
Eugenio Pucci
Alessandra Solari
Gruppo di Studio “Bioetica e Cure Palliative” of the Italian Neurological Society
Publikationsdatum: 12.01.2021
Verlag: Springer International Publishing
Schlagwort: COVID-19
Erschienen in: Neurological Sciences / Ausgabe 3/2021
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-020-04984-4

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Demenz | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The impact of the COVID-19 pandemic on people with neurological disorders: an urgent need to enhance the health care system’s preparedness

Excerpt

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2021

Successful treatment of cannabinoid administration against refractory epilepsy in Batten disease: a case report

Which are the factors influencing NIV adaptation and tolerance in ALS patients?

AChRAb and MuSKAb double-seropositive myasthenia gravis: a distinct subtype?

CIDP, CMT1B, or CMT1B plus CIDP?

Optic neuritis associated with sunitinib

Quality of life in neuro-Behçet’s disease: a cross-sectional study

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie